TechSeeker Profile

Teva Pharmaceuticals USA
Profile last edited on: 6/18/2013

NO Business Identifier is currently available for this company.
TS Type
Major Corp
Status
N/A
Year Founded
1901
Last Involved Year
2018

Key People / Management

  Martin Eglitis -- Senior Partnering Directo

  Gail Griffin --

  Tina C Guilder --

  Allen S Lefkowitz -- Senior Director, Business

  Kurt R Nielsen -- Executive Director, Gener

  Karl W Strohmeier --

Location Information

5 Basel Street PO Box 3190
Petach Tikva, IS 49131
   972 3 926 7267
   www.tevapharm.com

Public Profile

Teva Pharmaceutical Industries Limited engages in the development, production, and sale of a range of generic and branded pharmaceuticals, biogenerics, and active pharmaceutical ingredients (APIs) worldwide. The company?s principal products include Copaxone for multiple sclerosis; and Azilect for Parkinson?s disease. Teva Pharmaceutical also provides specialty pharmaceutical products, which include respiratory products based on its proprietary delivery systems, including Easi-Breathe, an advanced breath-activated inhaler; Spiromax/Airmax, a multidose dry powder inhaler; Steri-Nebs, the blow-fill-seal based nebulizers; and Cyclohaler, a single dose dry powder device. The company?s branded respiratory products include ProAir, a short-acting beta-agonist for the treatment of bronchial spasms and exercise-induced bronchospasm; and Qvar, an inhaled corticosteroid for long-term control of chronic bronchial asthma. In addition, it offers APIs for respiratory, cardiovascular, anti-cholesterol, central nervous system, dermatological, hormones, anti-inflammatory, oncology, immunosuppressants, and muscle relaxants. Further, the company provides women?s health care products, such as oral contraceptives, intrauterine contraception, and hormone therapy treatments for menopause/perimenopause, as well as therapies for use in infertility and urinary incontinence. It also holds a biotechnology platform focused on the development of peptide and protein-based medicines. Teva Pharmaceutical has cooperation agreements with Kowa Company, Ltd.; Lonza Group Ltd.; H. Lundbeck A/S; Impax Laboratories, Inc.; Anchen Pharmaceuticals, Inc.; sanofi-aventis; and OncoGenex Pharmaceuticals. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
Israel
Employment
45,754
Revenue
N/A
Public/Private
Publicly Traded
Stock Info
NYSE : TEVA
Received SBIR $$
No

Techseeker firm in the news

There are no news available.